首页> 外国专利> USE OF D1/D5 ANTAGONISTS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR TREATING OBSESSIVE COMPULSIVE DISORDERS, SOMATOFORM DISORDERS, DISSOCIATIVE, EATING DISORDERS, IMPULSE CONTROL DISORDERS AND AUTISM

USE OF D1/D5 ANTAGONISTS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR TREATING OBSESSIVE COMPULSIVE DISORDERS, SOMATOFORM DISORDERS, DISSOCIATIVE, EATING DISORDERS, IMPULSE CONTROL DISORDERS AND AUTISM

机译：D1 / D5拮抗剂在制备药物组合物中的用途，以治疗强迫性强迫症，躯体形式障碍，解体，进食障碍，冲动控制障碍和自闭症

页面导航

摘要
著录项
相似文献

摘要

A method for treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism is disclosed. These disorders are treated by administering an effective amount of a D1/D5 antagonist.

机译：公开了一种治疗强迫症，躯体形式障碍，解离性障碍，进食障碍，冲动控制障碍和自闭症的方法。通过施用有效量的D1 / D5拮抗剂来治疗这些疾病。

著录项

公开/公告号HU0101057A3

专利类型
公开/公告日2001-09-28

原文格式PDF
申请/专利权人 SCHERING CORPORATION KENILWORTH NEW JERSEY;
展开▼

申请/专利号HU20010001057
发明设计人
展开▼

申请日1999-03-01
分类号A61K31/55;
国家 HU
入库时间 2022-08-22 01:25:14

相似文献

专利
外文文献
中文文献